Eargo 8 vs Signia Pure C&G IX

The Eargo 8 is a premium-priced OTC hearing aid featuring an invisible-in-ear design with rechargeable batteries, priced at $2,399. In our lab testing, it earned a B grade with a SoundScore of 3.4/5, placing it in the top 71% of the OTC Hearing Aid category. Sound performance presents a mixed picture. The Eargo 8 delivers solid speech-in-quiet performance at 3.1/5, scoring 0.27 points above the category average—making it a reasonable choice for conversational settings without background noise. Own-voice comfort is another strength, measuring 0.69 points above average at 3.2/5, which may appeal to users who are sensitive to hearing their own voice through hearing aids. Feedback handling is strong in absolute terms at 4.2/5, though slightly below the category average. However, the device shows notable weaknesses in challenging listening environments. Speech-in-noise performance is low at 1.2/5, falling 0.27 points below the category average—users who frequently encounter noisy restaurants, busy offices, or social gatherings may find this limiting. Music streaming scored 0.0/5, significantly below the category average, making this device unsuitable for users who prioritize audio entertainment through their hearing aids. The Eargo 8 is best suited for users who prioritize discreet, invisible-in-ear styling and primarily need assistance in quieter conversational settings. However, at this premium price point, buyers should be aware that similarly-priced alternatives and even some lower-cost options may offer comparable or better overall sound performance.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.